Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-014354
Filing Date
2016-02-25
Accepted
2016-02-25 17:50:13
Documents
1
Period of Report
2016-02-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4179
  Complete submission text file 0000899243-16-014354.txt   5614
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Issuer) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 99 HAYDEN AVENUE, SUITE 390 LEXINGTON MA 02421
Business Address
Hava David L. (Reporting) CIK: 0001645110 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36199 | Film No.: 161457176